Position in AXGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,849,547
+$4,628,243 QoQ
Shares Held
126,641
+243.5% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#73
of 253 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $151,156,125 across 17 Medical Devices names. AXGN ranks #11 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
142,309 | $44,934,066 | |
| 2 | EW |
Edwards Lifesciences Corp
|
200,695 | $18,154,869 | |
| 3 | BSX |
Boston Scientific Corp
|
410,164 | $17,505,799 | |
| 4 | TNDM |
Tandem Diabetes Care Inc
|
700,000 | $10,563,000 | |
| 5 | MDT |
Medtronic plc
|
119,489 | $9,347,624 | |
| 6 | 320,442 | $7,972,596 | |||
| 7 | HAE |
Haemonetics Corp
|
105,508 | $7,913,100 | |
| 8 | IRTC |
iRhythm Holdings, Inc.
|
55,987 | $6,659,653 |
All Filings in AXGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,849,547 | 126,641 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,221,304 | 36,864 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $623,244 | 19,042 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,132,536 | 63,483 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $572,857 | 40,860 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $209,858 | 28,986 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $151,379 | 16,019 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||